The One, Big, Beautiful Bill | Drug Prices Debated | Markets Soar After US-China Tariff Deal

In this week’s episode of The Elliot Omanson Show, we break down the GOP’s newly proposed “One Big, Beautiful Bill” — and challenge the media’s narrative around it. Our focus is on the controversial Medicaid changes and spending cuts, with a take you won’t hear on most mainstream media.   We also unpack President Trump’s latest executive order aimed at lowering prescription drug prices through a “most-favored-nation” pricing model — a move that aligns U.S. costs with what other developed countries pay. Ironically, it's a policy many Democrats once supported… until Trump signed it.   Lastly, we cover the breakthrough U.S.–China trade talks in Geneva, where both countries agreed to drop tariffs by a staggering 115%. U.S. tariffs on Chinese goods drop to 30%, while China slashes its tariffs to just 10%. Markets surged on the news, with the Nasdaq and S&P 500 posting strong gains.   With trade momentum building, jobs strong, and inflation cooling — we think the American economy is poised to thrive.